Supplementary Training Workshop on Good Manufacturing Practices (GMP)

VALIDATION MASTER PLAN (VMP)

Jnos Pogny, pharmacist, PhD, consultant to WHO Pretoria, South Africa, 28 June 2005 E-mail: pogany@t-online.hu
2005.06.28. Dr. Pogny - WHO, Pretoria 1/26

Incidents/accidents leading to regulatory actions

1937 Sulfanilamide elixir 1962 Thalidomide 1982 Tylenol cyanide tampering 1989 Generic drug scandal (there is no new thing under the sun) 1970- Sterility problems found by FDA employees in the large-volume parenteral (LVP) industry
  

systems inspections by teams (engineers and microbiologists) validation as a requirement in the 1978 US-GMP terms protocol, qualification, and validation first used

2005.06.28.

Dr. Pogny - WHO, Pretoria

2/26

Systems approach
 water (generation, receipt, and distribution)  heating, ventilation, and air conditioning (HVAC)  sterilizers (operations, engineering, and configuration)  terminal sterilization of product  compressed air (generation and distribution)  premises  QC laboratories (analytical and microbiological)  production and control operations involved in the manufacture of LVPs
2005.06.28. Dr. Pogny - WHO, Pretoria 3/26

WHO GMP and Guidelines

 WHO good manufacturing practices (GMP): main principles for pharmaceutical products Section 4. Qualification and validation (see notes page below)
http://www.who.int/medicines/library/TRS/trs908/trs908-4.pdf

 Supplementary guidelines on good manufacturing practices (GMP): Validation Rev.1 (2003) Draft
http://www.who.int/medicines/organization/qsm/expert_committee/Guidelines/QAS_055_Rev1_validation.doc

 No specific guideline on the VMP.

2005.06.28. Dr. Pogny - WHO, Pretoria 4/26

Why do we validate?
 Interchangeability of generic FPPs = Pharmaceutical equivalence + bioequivalence  Pharmaceutical equivalence


 

Product and manufacturing process equivalence (prospective and concurrent validation) GMP equivalence (concurrent validation) Maintenance and continuous improvement of the validated status [concurrent and retrospective validation, Process Analytical Technology (PAT)]
Dr. Pogny - WHO, Pretoria 5/26

2005.06.28.

Why do we validate processes?

 Small quantity of waste creates serious danger to health (1/3 of 5% dextrose infusion was not sterile, Evans Medical, 1972)  Low chance that patient or doctor recognizes nonconformance to specification in time (1996 Haiti)  Limitations of sampling
 

Percent of nonconformance: 0,1 1,0 5,0 Percent probability of release: 98 82 36

10,0 12
6/26

2005.06.28.

Dr. Pogny - WHO, Pretoria

SAMPLING PROBLEM
The whole batch is released to the patient But only the sample is tested
2005.06.28.

BATCH

Sample
Dr. Pogny - WHO, Pretoria 7/26

4.4 What should be validated?

Any aspect of operation, including significant changes to the premises, facilities, equipment or processes, which may affect the quality of the product, directly or indirectly, should be qualified and validated.

2005.06.28.

Dr. Pogny - WHO, Pretoria

8/26

GMP, QUALIFICATION and

VALIDATION STARTS WITH DESIGN + CONSTRUCTION OF FACILITIES AND PURCHASING EQUIPMENT
2005.06.28. Dr. Pogny - WHO, Pretoria 9/26

Qualification Stage Key elements Premises and Equipment Design Installation Operation

Validation Stage Prospective Concurrent

Engineering phase

Manufacturing Start-Up

VMP

Validation Protocols

Validation Reports

Product and Process Validation of analytical methods

Laboratory Phase Critical variables and Process selection

Scale-Up Phase Process optimization

Manufacturing Phase Process & cleaning validation Revalidation

Quality Development
2005.06.28. Dr. Pogny - WHO, Pretoria 10/26

4.1-4.2 Validation master plan

1. In accordance with GMP, each pharmaceutical company should identify what qualification and validation work is required to prove that the critical aspects of their particular operation are controlled. 2. The key elements of a qualification and validation programme of a company should be clearly defined and documented in a validation master plan (VMP).
2005.06.28. Dr. Pogny - WHO, Pretoria 11/26

WHO draft guide

 The Validation Master Plan (VMP) complements the manufacturers site master file and should be the first document to be reviewed during inspection by a regulatory authority.  The VMP reinforces the commitment of the company to GMP. It is a formal policy document which describes the overall philosophy of the company towards validation and which also describes the key elements of the validation programme, organizational structure of validation, schedules and responsibilities.

2005.06.28.

Dr. Pogny - WHO, Pretoria

12/26

4.5-4.7 Validation policy

5. Qualification and validation should not be considered as one-off exercises. An on-going programme should follow their first implementation (continuous improvement within the design space speakers remark) and should be based on an annual review. 6. The commitment to maintain continued validation status should be stated in the relevant company documentation, such as the quality manual or validation master plan. 7. The responsibility of performing validation should be clearly defined.
2005.06.28. Dr. Pogny - WHO, Pretoria 13/26

Validation master plan

The VMP is a summary document and should therefore be brief, concise and clear. It should not repeat information documented elsewhere but refer to existing documents such as  Policy documents,  SOP's and  Validation Protocols/Reports.

2005.06.28.

Dr. Pogny - WHO, Pretoria

14/26

ISO9001 :2001 - 4.2.2 Quality manual

The organization shall establish and maintain a quality manual that includes a) the quality policy b) the scope of the quality management system, including details of and justification for any exclusions (see 1.2), c) the documented procedures established for the quality management system, or reference to them, and d) a description of the interaction between the processes of the quality management system.

2005.06.28.

Dr. Pogny - WHO, Pretoria

15/26

Types of VMP
 Construction of new premises  Introduction of a group of new FPPs (individual validation protocols may suffice for single new FPPs)  Major renovation or additions to existing premises  First time validation of previously unvalidated processes or unit operations  Automation or computerized implementations that span a number of applications
2005.06.28. Dr. Pogny - WHO, Pretoria 16/26

Functions of VMP
 Education of management  Project monitoring and management  Project training  Audit of the validation program  Update of regulatory agency requirements

2005.06.28.

Dr. Pogny - WHO, Pretoria

17/26

Basic questions to be answered

 What will be validated?  Who is responsible for the validation tasks?  How will the equipment be qualified and the processes validated?  How will the validation be documented?  What are the criteria by which a successful validation will be judged?

2005.06.28.

Dr. Pogny - WHO, Pretoria

18/26

Content of VMP
 Title, approval (top management and members of the validation team) and table of contents  Glossary of terms  Introduction (policy and objectives)  Scope [separate VMPs for manufacturing
processes, pharmaceutical utility systems (e.g. HVAC, water)].

 Responsibilities
2005.06.28. Dr. Pogny - WHO, Pretoria 19/26

Content of VMP
 Production and QC premises, including controlled
environments

 Process and QC equipment, including location  Pharmaceutical air (HVAC) and water systems  All potentially critical utilities (such as compressed
air, steam and cooling liquids, and so on)

 Computer control systems

2005.06.28. Dr. Pogny - WHO, Pretoria 20/26

Matrix for qualification of equipment

Equipment No. Description Unidirectional air flow hood High-speed mill High-speed, high shear granulator Sizer (re-granulator) Jacketed tank with stirrer Blender

IQ

OQ

PQ

2005.06.28.

Dr. Pogny - WHO, Pretoria

21/26

Content of VMP
 Manufacturing processes  List of validation protocols, including format  List of relevant SOPs  Product specifications including prospective (and tentative) IPC acceptance criteria  QC and IPC methods, validation, if applicable  Reasonable unexpected events

2005.06.28.

Dr. Pogny - WHO, Pretoria

22/26

Content of VMP
       Equipment cleaning Planning and scheduling (Gant chart) Preventative maintenance program Worker and environment safety Change Control/including Revalidation Training requirements Documentation requirements

2005.06.28.

Dr. Pogny - WHO, Pretoria

23/26

EU-VMP should contain at least the following data

a) validation policy b) organisational structure of validation activities c) summary of facilities, systems, equipment and processes to be validated d) documentation format: the format to be used for protocols and reports e) planning and scheduling f) change control g) reference to existing documents

2005.06.28.

Dr. Pogny - WHO, Pretoria

24/26

Main Points Again

 Target all personnel involved in the validation when creating the master plan.  Keep the VMP short, but provide enough information so that the document is functional.  Provide for flexibility to deal with changes, but do not avoid making the required decisions early on in the project.  The life cycle mandates that the validation process becomes an ongoing project, which requires constant attention.
2005.06.28. Dr. Pogny - WHO, Pretoria 25/26

Literature
 Qualification and validation, Annex 15 to the EU Guide to Good Manufacturing Practice
http://pharmacos.eudra.org/F2/eudralex/vol-4/pdfs-en/v4an15.pdf

 Validation Master Plan, Installation And Operational Qualification, Non-sterile Process Validation, Cleaning Validation (PIC/S, August 2001)  Model VMP for Tableting Plants (distributed among participants of the training course)
2005.06.28.

Dr. Pogny - WHO, Pretoria

26/26